Effect of folic acid fortification of food on homocysteine-related mortality

American Journal of Medicine

Volumn 116, Issue 3, 2004, Pages 158-164

  Anderson, Jeffrey L ^a,b   Jensen, Kurt R ^a   Carlquist, John F ^a   Bair, Tami L ^a   Horne, Benjamin D ^a   Muhlestein, Joseph B ^a  

^a UNIVERSITY OF UTAH   (United States)

^b LDS HOSPITAL   (United States)

Author keywords

Coronary artery disease; Folic acid; Food fortification; Homocysteine; Prevention

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA BASE; DIET SUPPLEMENTATION; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOLLOW UP; FOOD INTAKE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SOCIAL SECURITY;

EID: 1642430780     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.10.024     Document Type: Article

References (30)

1. Finkelstein J.D. The metabolism of homocysteine pathways and regulation . Eur J Pediatr. 154:(suppl 2):1998;S40-S44.
2. Eikelboom J.W., Lonn E., Genest J.J., Hankey G., Yusuf S. Homocyst(e)ine and cardiovascular disease a critical review of the epidemiologic evidence . Ann Intern Med. 131:1999;363-375.
3. Bellamy M.F., McDowell I.F.W., Ramsey M.W., et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation. 98:1998;1848-1852.
4. Nappo F., DeRosa N., Marfella R., et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA. 281:1999;2113-2118.
5. Graham I. Homocysteine in health and disease. [editorial] Ann Intern Med. 131:1999;387-388.
6. Boushey C.J., Beresford S.A., Omenn G.S., Motuldy A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease probable benefits of increasing folic acid intakes . JAMA. 274:1995;1049-1057.
7. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 337:1997;230-236.
8. Anderson J.L., Muhlestein J.B., Horne B.J., et al. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically-defined coronary artery disease. Circulation. 102:2000;1227-1232.
9. Wald D.S., Law M., Morris J.K. Homocysteine and cardiovascular disease evidence on causality from a meta-analysis . BMJ. 325:2002;1202-1209.
10. Lowering blood homocysteine with folic acid based supplements meta-analysis of randomised trials . BMJ. 316:1998;894-898.
11. Foulke J. Folic Acid to Fortify U.S. Food Products to Prevent Birth Defects. [press release]:1996;U.S. Food and Drug Administration, Washington, D.C.
12. Anderson J.L., Horne B.D., Carlquist J.F., et al. Effect of implementation of folic acid fortification of food on homocysteine concentrations in subjects with coronary artery disease. Am J Cardiol. 90:2002;536-539.
13. Taylor G.S., Muhlestein J.B., Wagner G.S., Bair T.L., Li P., Anderson J.L. Implementation of a computerized cardiovascular information system in a private hospital setting. Am Heart J. 136:1998;792-803.
14. Ubbink J.B., Vermaak W.J., van der Merwe A., Becker P.J. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 57:1993;47-53.
15. Selhub J., Jacques P.F., Wilson P.W., Rush D., Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 270:1993;2693-2698.
16. Malinow M.R., Duell P.B., Hess D.L., et al. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med. 338:1998;1009-1015.
17. Lawrence J.M., Petitti D.B., Watkins M., Umekubo M.A. Trends in serum folate after food fortification. [research letter] Lancet. 354:1999;915-916.
18. Komoromy-Hiller G., Nuttall K.L. Folic acid fortification. [letter] Lancet. 354:1999;2167-2168.
19. Chasan-Taber L., Selhub J., Rosenberg I.H., et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr. 15:1996;136-143.
20. Den Heijer M., Brouwer I.A., Bos G.M., et al. Vitamin supplementation reduces blood homocysteine levels a controlled trial in patients with venous thrombosis and healthy volunteers . Arterioscler Thromb Vasc Biol. 18:1998;356-361.
21. Jacques P.F., Selhub J., Bostom A.G., Wilson P.W., Rosenberg I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 340:1999;1449-1454.
22. Stubbs P.J., Al-Obaidi M.K., Conroy R.M., Collinson P.O., Graham I.M., Noble M.I.M. Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes. Circulation. 102:2000;605-610.
23. Schnyder G., Flammer Y., Roffi M., Pin R., Hess O.M. Plasma homocysteine levels and late outcome after coronary angioplasty. J Am Coll Cardiol. 40:2002;1769-1776.
24. Hoogeveen E.K., Kostense P.J., Jakobs C., et al. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes. Circulation. 101:2000;1506-1511.
25. Cleophas T.J., Hornstra M., van Hoogstraten B., van der Meulen J. Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis. Am J Cardiol. 86:2000;1005-1009.
26. Homocysteine and risk of ischemic heart disease and stroke. A meta-analysis. JAMA. 288:2002;2015-2022.
27. Klerk M., Verhoef P., Clarke R., et al. MTHFR 677C-T polymorphism and risk of coronary heart disease. A meta-analysis. JAMA. 288:2002;2023-2031.
28. Virdis A., Ghiadoni L., Cardinal H., et al. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol. 38:2001;1106-1115.
29. Doshi S.N., McDowell I.F.W., Moat S.J., et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation. 105:2002;22-26.
30. Clarke R., Collins R. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. J Cardiovasc Risk. 5:1998;249-255.